Norway $2.2 Trillion Fund Lost 1.9% Led by Tech Stocks Slide
Original Report
Norway’s wealth fund lost 1.9% in the first quarter, dragged down by investments in US technology stocks as the war in the Middle East rattled markets.
Glass House Analysis
This story reflects the interconnected nature of modern economic systems, where developments in one sector inevitably affect others. Understanding these connections is essential for grasping how policy decisions and market movements translate into real-world outcomes for families, workers, and communities. The economy is not an abstract system of numbers—it's the sum total of decisions about who works, who prospers, and who struggles.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
U.S. Senate votes to advance $70 billion funding plan for ICE, Border Patrol
U.S. Senate Republicans voted on Thursday to advance a $70 billion plan to fund the Immigration and Customs Enforcement and Border Patrol agencies.
War Shock to Global Economy Ripples Unevenly as Euro Zone Reels
The global economy just endured a second month of renewed price pressures but with less synchronized fallout on growth, according to the first take of business surveys for April.
The meme-stock craze is getting close to its post-Liberation Day extremes, according to JPMorgan
Analysts at the world’s biggest bank said crowding in meme stocks has approached close to the extremes reached after President Donald Trump imposed his ‘Liberation Day’ tariffs
Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment
Currency effects weighed on the Swiss drugmaker's first-quarter earnings